Strides Shasun today said it has received an approval from the US health regulator for Abacavir tablets used in the treatment of HIV.
In a BSE filing, Strides Shasun said "it has received approval from the United States Food and Drug Administration (USFDA) for Abacavir Tablets USP, 300 mg".
The product will be manufactured at the company's USFDA approved facility at Bengaluru and marketed by Strides in the US market.
Also Read
"The product will be launched immediately," it added.
According to IMS sales data, the US market for Abacavir is approximately USD 30 million.
Strides Shasun stock was trading 0.96 per cent higher at Rs 1,053 apiece on BSE in morning trade.
Disclaimer: No Business Standard Journalist was involved in creation of this content
